Breaking News
Get 45% Off 0
🤯 +96%, +62%, +40%: These AI-picked stocks are soaring!
See the list

The Zacks Analyst Blog Highlights: UnitedHealth, Pacira, Turning Point, Coca-Cola And Sempra

By Zacks Investment ResearchStock MarketsMar 13, 2020 12:14AM ET
www.investing.com/analysis/the-zacks-analyst-blog-highlights-unitedhealth-pacira-turning-point-cocacola-and-sempra-200515994
The Zacks Analyst Blog Highlights: UnitedHealth, Pacira, Turning Point, Coca-Cola And Sempra
By Zacks Investment Research   |  Mar 13, 2020 12:14AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
 
US500
-1.76%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
DJI
-1.48%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
GS
-2.74%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
KO
+1.56%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
SRE
-0.18%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
UNH
-1.67%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

For Immediate Release

Chicago, IL – March 13, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include UnitedHealth Group Inc. (NYSE:UNH) , Pacira BioSciences, Inc. (NASDAQ:PCRX) , Turning Point Brands, Inc. (NYSE:TPB) , The Coca-Cola Company (NYSE:KO) and Sempra Energy (NYSE:SRE) .

Here are highlights from Thursday’s Analyst Blog:

5 Best Stocks to Buy in a Coronavirus-Led Bear Market

It seems the U.S. stock market’s bull run is coming to an end. The Dow has already plunged into the bear-market territory for the first time in a decade. And the blue-chip index’s descend from a recent peak has been the fastest since the Great Depression. This time, it just took 19 trading days for the 30-stock average to enter bear market, while in November 1931, when the Great Depression was evolving, the index took a brisk 15 days to pullback at least 20%.

Other major benchmarks, including the broader S&P 500, are also headed for a bear market. What’s more, the period of a typical bear market has a propensity to be pretty lengthy. On average, bear market for the Dow and the S&P 500 lasts for 206 and 146 trading days, respectively, per data compiled by Dow Jones Market Data. U.S. stocks, by the way, had already slipped into correction mode in February.

But what’s dragging stocks into a bear market? Investors are particularly tensed about the economic impact of the fast spread of coronavirus across the globe. Several companies have already raised alarm bells about the outbreak weighing on their earnings, and supply chains getting disrupted. And it will certainly lead to both a demand and a supply shock for the global economy, as it mostly erupted in China. After all, China is one of the world’s largest exporters and importers of goods.

Top equity strategist at Goldman Sachs (NYSE:GS), David Kostin, thus expects S&P 500 companies to see a collective drop of almost 15% in their earnings for the second quarter, and a drop of around 12% in the third.

Meanwhile, President Trump failed to quell worries about the possible economic slowdown from the coronavirus. In an attempt the curb the negative impact of the virus on the economy, he announced travel restrictions with Europe, and promised to offer “a payroll tax cut or relief” to both business houses and hourly wage earners.

But his proposals were received with skepticism from both Democrats and Republicans, as they were mostly looking for a more robust fiscal policy to counter slowing economic growth. At the same time, it’s quite evident, not all his proposed plans are likely to get passed in the Democratic-controlled House of Representatives. In fact, U.S. Treasury Secretary Steven Mnuchin did mention that it will take some time for the economic stimulus measures to get through Congress.

Recently, the World Health Organization declared the coronavirus outbreak a global pandemic. After all, governments from Italy to California have imposed bans on public gatherings in a move to restrict the spread of the illness. And this restriction in consumer movement will ultimately impact economic growth worldwide.

Which Stocks to Buy in a Bear Market?

No doubt, when the broader market nosedives, companies that offer big-ticket items like autos, machinery, high technology and home improvement items tend to take a beating. After all, they are cyclical stocks and do well when the economy is in a sound condition. But when the market is tanking and the economy is feared to enter a recession, it pays to switch to defensive sectors like healthcare, consumer staples and utilities. Stocks from these sectors are generally non-cyclical, or companies whose business performance and sales are not highly correlated with the activities in the larger market.

Health is no doubt a priority, and consumers will continue to avail healthcare products and services in difficult economic times. Similarly, food, beverage and tobacco companies are true defensive plays as demand for such staple stocks remains unaltered during market gyrations. Utilities too are deemed defensive stocks as electricity, gas and water are essentials.

5 Solid Choices

We have selected five solid stocks from the aforesaid areas that should make meaningful additions to your portfolio. These stocks flaunt a Zacks Rank #1 (Strong Buy) or 2 (Buy).

UnitedHealth Group Inc.operates as a diversified health care company in the United States. The company has a Zacks Rank #2. The Zacks Consensus Estimate for its current-year earnings has moved 0.1% up over the past 60 days. The company’s expected earnings growth rate for the next quarter and current year is 16.7% and 9%, respectively.

Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions. The company has a Zacks Rank #2. The Zacks Consensus Estimate for its current-year earnings has risen 19.8% over the past 60 days. The company’s expected earnings growth rate for the current quarter and year is 109.1% and 52.1%, respectively.

Turning Point Brands, Inc. provides tobacco products in the United States. The company has a Zacks Rank #1. The Zacks Consensus Estimate for its current-year earnings has climbed 5.1% over the past 60 days. The company’s expected earnings growth rate for the current quarter and year is 9.3% and 10.2%, respectively. You can see the complete list of today’s Zacks #1 Rank stocks here.

The Coca-Cola Companyhas a Zacks Rank #2. The Zacks Consensus Estimate for its current-year earnings has moved 0.4% north over the past 60 days. The company’s expected earnings growth rate for the next quarter and current year is 4.8% and 6.6%, respectively.

Sempra Energydevelops and operates energy infrastructure. The company has a Zacks Rank #2. The Zacks Consensus Estimate for its current-year earnings has risen 3.2% over the past 60 days. The company’s expected earnings growth rate for the next quarter and current year is 12.7% and 5.2%, respectively.

The Hottest Tech Mega-Trend of All

Last year, it generated $24 billion in global revenues. By 2020, it's predicted to blast through the roof to $77.6 billion. Famed investor Mark Cuban says it will produce ""the world's first trillionaires,"" but that should still leave plenty of money for regular investors who make the right trades early.

See Zacks' 3 Best Stocks to Play This Trend >>

Join us on Facebook (NASDAQ:FB): http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com

http://www.zacks.com

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.



UnitedHealth Group Incorporated (UNH): Free Stock Analysis Report

Sempra Energy (SRE): Free Stock Analysis Report

Coca-Cola Company (The) (KO): Free Stock Analysis Report

Pacira Pharmaceuticals, Inc. (PCRX): Free Stock Analysis Report

Turning Point Brands, Inc. (TPB): Free Stock Analysis Report

Original post

Zacks Investment Research

The Zacks Analyst Blog Highlights: UnitedHealth, Pacira, Turning Point, Coca-Cola And Sempra
 

Related Articles

The Zacks Analyst Blog Highlights: UnitedHealth, Pacira, Turning Point, Coca-Cola And Sempra

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email